Novelgenix Therapeutics Private Limited

Develops innovative generic products for specialist medical therapies worldwide.

2011 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Novelgenix Therapeutics Profile

Key Indicators

  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 0.18 M
  • Company Age 13 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -95.89%
  • Profit Growth 6.23%
  • Ebitda 5.41%
  • Net Worth -3080.52%
  • Total Assets -28.96%

About Novelgenix Therapeutics

Novelgenix Therapeutics Private Limited (NTPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 June 2011 and has a history of 13 years and nine months. Its registered office is in Ahmedabad, Gujarat, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 0.18 M, as per Ministry of Corporate Affairs (MCA) records.

Shivprakash Chinnappa, Monika Verma, and Harsh Rathnam serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74140GJ2011PTC065969

  • Company No.

    065969

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    20 Jun 2011

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Novelgenix Therapeutics Private Limited offer?

Novelgenix Therapeutics Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Company Law & Labour Law Consultants, Statutory Compliance Services, Research and Development (R&D) Work, Product Development Research, Rapid Test Kit, Diagnostic Test Kit, Computer and Networking Solutions, Networking Solutions.

Company report

Novelgenix Therapeutics Private Limited

Explore comprehensive data for Novelgenix Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Novelgenix Therapeutics?

Executive Team (1)

NameDesignationAppointment DateStatus
Shivprakash Chinnappa Country flag representing In Managing Director20-Jun-2011Current

Board Members (2)

NameDesignationAppointment DateStatus
Monika Verma Country flag representing In Director Current
Harsh Rathnam Country flag representing In Director 09-Jun-2022Current

Financial Performance of Novelgenix Therapeutics.

Novelgenix Therapeutics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 95.89% decrease. The company also saw a slight improvement in profitability, with a 6.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 3080.52%.

Novelgenix Therapeutics revenue growth over time
Novelgenix Therapeutics profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-95.89%
Revenue from Operations
Total Assets
-28.96%
Profit or Loss
6.23%
Net Worth
-3080.52%
EBITDA
5.41%

What is the Ownership and Shareholding Structure of Novelgenix Therapeutics?

In 2023, Novelgenix Therapeutics had a promoter holding of 83.78% and a public holding of 16.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Novelgenix Therapeutics?

Unlock and access historical data on people associated with Novelgenix Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Novelgenix Therapeutics Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novelgenix Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novelgenix Therapeutics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Novelgenix Therapeutics

Recent activity within the organization

  • Annual General Meeting

    Novelgenix Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Novelgenix Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

  • Director Appointment

    Harsh Shivprakash Rathnam was appointed as a Director was appointed as a Director on 09 Jun 2022 & has been associated with this company since 2 years 10 months .

  • Director Appointment

    Shivprakash Chinnappa was appointed as a Managing Director was appointed as a Managing Director on 20 Jun 2011 & has been associated with this company since 13 years 9 months .

  • Company Incorporation

    Novelgenix Therapeutics Private Limited was registered on 20 Jun 2011 with Roc Ahmedabad & aged 13 years 9 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Novelgenix Therapeutics Private Limited?

    Novelgenix Therapeutics Private Limited was incorporated on 20 Jun 2011.

  • What is authorized share capital and paid-up capital of Novelgenix Therapeutics Private Limited?

    The authorized share capital of Novelgenix Therapeutics Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 0.18 M.

  • Who are the current board members & directors of Novelgenix Therapeutics Private Limited?

    Currently 3 directors are associated with Novelgenix Therapeutics Private Limited.

    • Shivprakash Chinnappa
    • Monika Kamalnain Verma
    • Harsh Shivprakash Rathnam

  • What is the registered address of Novelgenix Therapeutics Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Novelgenix Therapeutics Private Limited is 405A Pinnacle Corporate Road Prahaladnagar, Satellite India, Ahmedabad, Gujarat, 380015.

  • What is the corporate identification number (CIN) and company number of Novelgenix Therapeutics Private Limited?

    The corporate identification number (CIN) of Novelgenix Therapeutics Private Limited is U74140GJ2011PTC065969 and the company number is 065969 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Novelgenix Therapeutics Private Limited?

    The Official website of Novelgenix Therapeutics Private Limited is https://www.novelgenix.com

  • What has been the recent revenue trend for Novelgenix Therapeutics Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Novelgenix Therapeutics Private Limited has fallen by -95.89%.

  • What change has been observed in the net worth of Novelgenix Therapeutics Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Novelgenix Therapeutics Private Limited has experienced an downturn of -3080.52%.

  • When was the last Balance Sheet of Novelgenix Therapeutics Private Limited filed with the ROC?

    The most recent Balance Sheet for Novelgenix Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharma Contract R&D